Thank you, Stephan. I'll begin with our Q3 financial highlights on Slide 10, before getting into more details. Overall, Q3 net sales were within our range of expectations, whereas adjusted EBITDA dollars and margins, operating cash flows, and debt reduction, were all significantly above expectations. Therefore, given our strong operating performance in the quarter, we are raising our adjusted EBITDA expectations for the year. Looking at some of the details for the third quarter, net sales were $1.2 billion down, 3.2% versus Q3 of last year. Reported net sales were negatively impacted by 290 basis points of FX headwinds year-over-year. On a constant currency basis, net sales were nearly flat versus Q3 2023. Our third quarter adjusted EBITDA was $167 million and exceeded our guidance range of $125 million to $155 million. Adjusted EBITDA margin was 13.4%, up 70 basis points versus Q3 2023. Q3 marks yet another quarter of strong operating results driven by our restructuring and cost saving initiatives. CapEx for the third quarter was $27 million below the low end of our guidance range of $35 million to $45 million. A portion of the underspent was due to timing of certain projects being shifted to Q4. In addition, we incurred approximately $3 million of capitalized SaaS implementation costs in the quarter. Q3 gross profit margins improved to 78.3% up 200 basis points compared to the third quarter of last year. The increase in gross profit margin was primarily due to pricing actions we have taken over the past year, which drove approximately 110 basis points of benefit along with an additional 110 basis points of favorability from reduced input cost mainly related to manufacturing efficiencies and lower raw material costs. Unfavorable sales mix had an approximately 30 basis points negative impact on margin year-over-year. Q3 diluted EPS of $0.46 with adjusted diluted EPS of $0.57, which included a $0.10 FX headwind versus Q3 of 2023. Q3 diluted EPS was favorably impacted by approximately $4 million pre-tax gain related to the sales of our office building in Torrance, California, which is excluded from our adjusted results. Our Q3 adjusted effective tax rate was 22.3% down from 30.3% in the third quarter of 2023, which drove an approximate $0.06 unfavorable impact to adjusted diluted EPS. The lower effective tax rate in 2024 was primarily due to changes in geographic mix of income partially offset by the tax impact of elevated interest expense following our recent debt refinancing. We continue to expect a full year 2024 adjusted effective tax rate to be approximately 30%. We had strong cash generation in the quarter. Operating cash flows were $100 million, which included approximately $28 million of cash payments related to the restructuring program. In addition, we received net proceeds of approximately $38 million related to the sales of our Torrance office building in July, which are incremental to the operating cash flows. We have until the end of November 2025 to move out of that building, which gives us adequate time to relocate our employees as well as our R&D and quality labs to other office locations in Southern California. We expect to incur about $8 million of one-time capital cost next year to do so. And as Michael noted earlier, we pay down $85 million of debt in the quarter. Credit agreement EBITDA for the third quarter was $197 million and our total leverage ratio is down to 3.3x as of September 30 from 3.5x at the end of June. For additional details regarding the adjustments between adjusted EBITDA and credit agreement EBITDA, as well as the calculation of our total leverage ratio, please refer to our presentation appendix and the earnings press release. Turning to Slide 11. We see the drivers of our year-over-year net sales performance. On a reported basis, net sales were down 3.2% year-over-year and nearly flat on a constant currency basis. Overall volumes declined by 5.4% year-over-year leading to an approximately $70 million headwind, which was partially offset by approximately $62 million in pricing benefits. FX was approximately $37 million headwind year-over-year or 290 basis points in line with the approximate 300 basis point headwind we anticipated in July. Turning to Slide 12. We have the regional net sales results for the third quarter. On a local currency basis, Latin America, EMEA, and Asia-Pacific all reported net sales growth in the quarter, with FX negatively impacting each of these regions on a reported basis. Latin America net sales were down 2% on a reported basis, while up 9% on a local currency basis. Favorable year-over-year pricing was more than offset by unfavorable FX headwinds, primarily due to the Mexican peso and continued devaluation of the Argentinian peso, with overall volumes in the region relatively flat. We continue to take regular price increases in Argentina to offset the FX headwinds. On a reported basis, Mexico's net sales were down 4% year-over-year, whereas on a local currency basis, net sales were up 6% year-over-year, driven by a 5.25% price increase in March 2024, partially offset by slightly lower volumes. It's worth noting the overall impact of the 5% price reduction that most markets in the regions implemented in Q2, excluding Mexico was not mature to the Q3 year-over-year pricing impact, as a majority of these markets also instituted price increases in Q1 of 2024. However, we believe the Q2 price changes may have positively contributed to the year-over-year volume increases in several of the markets in Q3 of this year. EMEA net sales were relatively flat year-over-year, with local currency net sales up 2% favorable year-over-year pricing and sales mix impacts were mostly offset by volume decline and unfavorable FX headwinds. Year-over-year results were generally mixed across the markets in the region. In Asia-Pacific, net sales were down 1% year-over-year on a reported basis, while up 1% on a local currency basis. In India, net sales were up 1% on a reported basis and 3% in local currency with pricing benefits more than offsetting a slight decline in volumes year-over-year. In North America, net sales were down 6% year-over-year, a slight improvement from the Q2 2024 year-over-year decline. This is the second quarter in a row we have seen improvement in the year-over-year trends. As Stephan noted in his opening remarks, our new distributor metrics are encouraging and we have several new initiatives in the region that are beginning to gain traction. We believe the gradual improvement is a positive indication of our path back to growth. China net sales decreased 16% year-over-year and were down 17% on a local currency basis. As Stephan noted, we are seeing a significant increase in the number of preferred customers signing up following the launch of the new customer loyalty program and the Herbalife Premier League, which led to less focus on sales representative improvement. The China team has made some changes to the Herbalife Premier League qualification requirements during the third quarter to encourage more recruitment of both customers and sales representatives. We continue to be encouraged by the number of new customers joining; however, we need time to observe the customer lifetime earth performance and the flow from PC to sales representative to assess how it will translate to sustainable growth. Moving to Slide 13, we see the drivers of our year-over-year increase in our adjusted EBITDA. Q3 adjusted EBITDA was $167 million with the margin at 13.4% up 70 basis points year-over-year. Looking at the bridge, the impact of the gross profit margin improvement can be seen in the benefits of price increases and favorable input costs partially offset by lower volumes and sales mix. Employee bonus accrual continues to be a headwind up around $16 million year-over-year and consistent with the expectations we communicated in Q1 of this year. Given the restructuring program and bonus level accrued already as of September, we don't expect additional unfavorable bonus impact in Q4. Technology costs were up approximately $5 million year-over-year primarily due to increased SaaS hosting fees. Q3 2024 adjusted EBITDA benefited from $5 million of China government grant income recognized in the quarter with no similar income in Q3 2023. And as I stated last quarter, we had a large distributor event that took place in the third quarter of this year, which was held in the fourth quarter of last year driving a $7.2 million headwind to adjusted EBITDA in Q3 2024, which is included in the other bucket, unfavorable year-over-year FX limits led to an approximately $14 million year-over-year reduction in adjusted EBITDA. Moving to Slide 14, I'll provide an update on our capital structure. During the quarter, we repaid $85 million in debt, $5 million of the term loan fee, scheduled amortization payment, and $80 million on the revolving credit facility. As of September 30, the revolving credit facility was fully under owned. As I noted earlier, we further reduced our total leverage ratio to 3.3x as of September 30. And we believe we are on track to reduce our total leverage ratio to 3x by the end of 2025 following the repayment of the 2025 notes. In accordance with the terms of our credit facility, we plan to repay at least $62 million of the 2025 notes by the beginning of March next year, with the remainder of the 2025 notes to be paid at or prior to the September 2025 maturity. Over the next four plus years, we plan to repay $1 billion debt, including the $85 million repaid in the quarter. Moving to Slide 15, we will review our outlook for the fourth quarter and full year. For the fourth quarter, we expect net sales to be in the range of up 1% to down 3% year-over-year. We expect adjusted EBITDA to be in the range of $105 million to $135 million. And our planned capital expenditures for the fourth quarter are in the range of $25 million to $45 million. In addition, we expect Q4 capitalized SaaS implementation costs to be approximately $7 million, which is incremental to our planned CapEx. Based on our results through the third quarter and the outlook for the remainder of the year, we have updated our guidance for the full year 2024. Our full year net sales guidance is now in the range of down 1% to down 2% versus last year. We are raising our expectations for the full year adjusted EBITDA to a range of $590 million to $620 million. And we reduced the top end of our capital expenditure range to now be between $120 million to $140 million. And one last comment before we move to Q&A. Herbalife, even with our near-term elevated capital expenditures for technology, continues to generate significant cash flows. And we plan to use these cash flows to reduce debt by $1 billion over the next four plus years and believe we can accomplish this goal by the end of 2028. This concludes our opening remarks. Operator, please open the call for questions.